Our goal is to incorporate genomics, electronic health records, and biomedical informatics to realize precision medicine for neurodegenerative diseases.
Equity for Latinx/Hispanic Healthy Aging (ELHA) Lab
The “Equity for Latinx/Hispanic Healthy Aging” (ELHA) Lab focuses on the prevention, early detection/diagnosis, and management of Alzheimer’s disease and related dementias in Latine/Hispanic communities.
Peng Lab focuses on the molecular and cellular mechanisms of alpha-synuclein and tau related neurodegenerative diseases including but not limited to Parkinson’s disease, Alzheimer’s disease and multiple system atrophy.
The Rexach Lab uses systems biology and functional genomics approaches to understand neurodegenerative dementias, such as Alzheimer's disease, frontotemporal dementia, and progressive supranuclear palsy.